{
    "2021-08-23": [
        [
            {
                "time": "",
                "original_text": "机构买入评级大幅扩围，64股看涨逾70%",
                "features": {
                    "keywords": [
                        "机构",
                        "买入评级",
                        "扩围",
                        "看涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：药明康德、迈瑞医疗等市值底部已现 无需恐慌",
                "features": {
                    "keywords": [
                        "医药生物",
                        "药明康德",
                        "迈瑞医疗",
                        "市值底部"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "8月备受基金公司关注的三个行业：医药医疗、电气设备、工业机械",
                "features": {
                    "keywords": [
                        "8月",
                        "基金公司",
                        "医药医疗",
                        "电气设备",
                        "工业机械"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "电气设备",
                        "工业机械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国金证券首予华东医药买入评级：医药工业品质技术升级，医美全球逐步开花，目标价45.1元",
                "features": {
                    "keywords": [
                        "国金证券",
                        "华东医药",
                        "买入评级",
                        "医药工业",
                        "品质技术升级",
                        "医美",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}